TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
62 hedge funds and large institutions have $20.9M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% less capital invested
Capital invested by funds: $45M → $20.9M (-$24.1M)
78% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 23
Holders
62
Holding in Top 10
1
Calls
$545K
Puts
$187K
Top Buyers
| 1 | +$474K | |
| 2 | +$472K | |
| 3 | +$191K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$49.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$41.7K |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$1M | |
| 3 | -$467K | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$363K |
| 5 |
D.E. Shaw & Co
New York
|
-$280K |